hydrochlorothiazide and dapagliflozin

hydrochlorothiazide has been researched along with dapagliflozin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Zeeuw, D; Lambers Heerspink, HJ; Leslie, B; List, J; Wie, L	1
Biancalana, E; Bruno, RM; Dardano, A; Ghiadoni, L; Giannini, L; Parolini, F; Rossi, C; Seghieri, M; Solini, A; Taddei, S	1

Trials

2 trial(s) available for hydrochlorothiazide and dapagliflozin

Article	Year
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes. Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:9 Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Humans; Hydrochlorothiazide; Hypoglycemic Agents; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Weight Loss	2013
The Effects of Dapagliflozin on Systemic and Renal Vascular Function Display an Epigenetic Signature. The Journal of clinical endocrinology and metabolism, 2019, 10-01, Volume: 104, Issue:10 Topics: Adult; Aged; Analysis of Variance; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Epigenesis, Genetic; Female; Glomerular Filtration Rate; Glucosides; Hospitals, University; Humans; Hydrochlorothiazide; Hypertension; Italy; Male; MicroRNAs; Middle Aged; Prognosis; Renal Circulation; Sodium-Glucose Transporter 2 Inhibitors; Statistics, Nonparametric; Treatment Outcome; Up-Regulation	2019

Article

Year

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes.

Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:9

Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Humans; Hydrochlorothiazide; Hypoglycemic Agents; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Weight Loss

2013

The Effects of Dapagliflozin on Systemic and Renal Vascular Function Display an Epigenetic Signature.

The Journal of clinical endocrinology and metabolism, 2019, 10-01, Volume: 104, Issue:10

Topics: Adult; Aged; Analysis of Variance; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Epigenesis, Genetic; Female; Glomerular Filtration Rate; Glucosides; Hospitals, University; Humans; Hydrochlorothiazide; Hypertension; Italy; Male; MicroRNAs; Middle Aged; Prognosis; Renal Circulation; Sodium-Glucose Transporter 2 Inhibitors; Statistics, Nonparametric; Treatment Outcome; Up-Regulation

2019